To be able to develop new treatments, researchers and clinicians need to understand the biology for each different type of ovarian cancer. Since low grade serous is less common, less research has been carried out on this type of ovarian cancer. Hear from Professor Charlie Gourley (Clinical Director of the Cancer Research UK Scotland Centre) about the valuable information his recent research project has contributed, and how the findings can hopefully be built on to develop new treatments. Dr Emma Dennett (Target Ovarian Cancer's Research Manager) also shares more about Target Ovarian Cancer’s research programme.
Missed one of our recent Ask the Expert Q&A events?
Why not catch up on demand with our YouTube playlist? All our events are tailored, so you can find the topics that interest you and choose the type of support that suits you and your loved ones – there’s lots to explore.
